Affinity DataIC50: 6.00E+3nMAssay Description:Inhibition of human cytochrome P450 3A4 as total cyclosporin oxidation (1 uM)More data for this Ligand-Target Pair
Affinity DataIC50: 1.00E+4nMAssay Description:Inhibition of human cytochrome P450 1A2 activity as caffeine N3 demethylation (500 uM)More data for this Ligand-Target Pair
Affinity DataIC50: 1.10E+4nMAssay Description:Inhibition of human cytochrome P450 2D6 as bufuralol 1''-hydroxylation (10 uM)More data for this Ligand-Target Pair
Affinity DataIC50: 2.60E+4nMAssay Description:Inhibition of human cytochrome P450 2C19 as S-mephenytoin-4-hydroxylation (100 uM)More data for this Ligand-Target Pair
Affinity DataIC50: 3.20E+4nMAssay Description:Inhibition of human cytochrome P450 2D6 as bufuralol 1''-hydroxylation (10 uM)More data for this Ligand-Target Pair
Affinity DataIC50: 4.00E+4nMAssay Description:Inhibition of human cytochrome P450 3A4 as total cyclosporin oxidation (1 uM)More data for this Ligand-Target Pair
Affinity DataIC50: 4.60E+4nMAssay Description:Inhibition of human cytochrome P450 2C19 as S-mephenytoin-4-hydroxylation (100 uM)More data for this Ligand-Target Pair
Affinity DataIC50: 6.60E+4nMAssay Description:Inhibition of human cytochrome P450 1A2 activity as caffeine N3 demethylation (500 uM)More data for this Ligand-Target Pair
Affinity DataIC50: >1.00E+5nMAssay Description:Inhibitory potential of human cytochrome P450 2C9 as tolbutamide methylhydroxylation (100 uM)More data for this Ligand-Target Pair
Affinity DataIC50: >1.00E+5nMAssay Description:Inhibitory potential of human cytochrome P450 2C9 as tolbutamide methylhydroxylation (100 uM)More data for this Ligand-Target Pair